StockData
Biohaven Ltd. logo

Biohaven Ltd. (BHVN) stock

BHVNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 1/30
$13.24−0.56 (-4.06%)

Close on Nov 17, 2026Market cap $2.00BP/E –Yield –

Biohaven total assets

Total assets on the balance sheet at the end of each period.

Biohaven's total assets was $263.68M at Sep 30, 2026. For fiscal 2025 it was $451.45M, down 26.6% from the year before. The highest annual figure on record is $661.78M in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$451.45M-26.6%
FY2024Dec 31, 2024$615.11M+19.9%
FY2023Dec 31, 2023$513.21M-22.5%
FY2022Dec 31, 2022$661.78M+365.8%
FY2021Dec 31, 2021$142.06M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$263.68M-35.6%
Q2 FY2026Jun 30, 2026$370.74M-32.6%
Q1 FY2026Mar 31, 2026$466.41M+1.6%
Q4 FY2025Dec 31, 2025$451.45M-26.6%
Q3 FY2025Sep 30, 2025$409.12M-19.9%
Q2 FY2025Jun 30, 2025$550.42M-5.5%
Q1 FY2025Mar 31, 2025$458.95M+9.7%
Q4 FY2024Dec 31, 2024$615.11M+19.9%
Q3 FY2024Sep 30, 2024$510.52M+33.4%
Q2 FY2024Jun 30, 2024$582.64M+15.0%
Q1 FY2024Mar 31, 2024$418.53M-32.3%
Q4 FY2023Dec 31, 2023$513.21M-22.5%
Q3 FY2023Sep 30, 2023$382.74M+182.2%
Q2 FY2023Jun 30, 2023$506.74M+256.7%
Q1 FY2023Mar 31, 2023$618.52M–
Q4 FY2022Dec 31, 2022$661.78M–
Q3 FY2022Sep 30, 2022$135.65M–
Q4 FY2021Dec 31, 2021$142.06M–

More Biohaven figures

See a number that looks wrong?